Piramal Critical Care has reserved commercialisation rights for the EU, UK, and Norway and will look after Neoatricon in ...

Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced the successful completion of the Phase III clinical study ...

Ozempic and alcohol-use disorder were central to a recent study that showed the weight-loss drug helped decrease bingeing. Is ...

2."Shopping addiction is a compulsive behavior just like any other addiction. It provides the same cycle of temporary reward ...

Developed by Ireland-based BrePco Biopharma, Neoatricon is the first paediatric-strength dopamine hydrochloride infusion for ...

Opinion: DLA Piper's Chris Gismondi and Angela Agrusa say courts need to be careful with addiction suits, as doctors haven't ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behavior or ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

“The fact that we are able to record these signals, such as dopamine and acetylcholine, is important for the study of drug abuse or attention,” he says. “There are many, many different lines ...

Tony Murphy was a solid 20-a-day smoker. His attempts at quitting lasted at best days, often only hours, as his craving for a ...

Caffeine in coffee offers surprising health benefits, although energy drinks may be harmful. Here's what you need to know.

Study reveals the structure of PINK1 protein, offering fresh hope for Parkinson's patients through potential targeted ...